Sign in
8-K

Current Report

WEST PHARMACEUTICAL SERVICES INC Filed Acc 0000105770-07-000368

Exit or restructuring costs · Impairment · Executive or director change · Bylaws or fiscal year change

  • Item 2.05 Costs associated with exit or disposal activities
  • Item 2.06 Material impairments
  • Item 5.02 Departure or appointment of directors or officers
  • Item 5.03 Amendments to articles or bylaws; change in fiscal year

From the SEC's structured data for this filing

Loading file8k.htm…